Circulating PD-1+ effector memory T cells predict anti-PD-1 efficacy in advanced gastric cancer

Kongcheng Wang, Jie Shao, Kai Xin, Lianru Zhang, Baorui Liu, Wenxiu Chen, Qin Liu · 2025

Read Circulating PD-1+ effector memory T cells predict anti-PD-1 efficacy in advanced gastric cancer by Kongcheng Wang, Jie Shao, Kai Xin, Lianru Zhang, Baorui Liu, Wenxiu Chen, Qin Liu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12727954.txt.

Description

Kongcheng Wang and six co-authors present a 2025 study on a blood test that may predict who benefits from immunotherapy in advanced stomach cancer. Checkpoint drugs help only a minority, and markers are urgently needed. Before treatment, the team measured how many of a patient's circulating memory T cells carried the PD-1 target protein, comparing fifty-four patients who later responded or did not.

Responders started with a higher share of such cells, and above a cutoff of about nine percent, patients progressed more slowly. The marker stayed independently protective after full adjustment. In the lab, blocking PD-1 woke these cells up, raising their killing power and signal output. The authors propose the simple blood measure as a guide for choosing chemo-immunotherapy. It could spare non-responders a treatment unlikely to help.

Catalog record

CREATORKongcheng Wang, Jie Shao, Kai Xin, Lianru Zhang, Baorui Liu, Wenxiu Chen, Qin Liu
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12727954

Browse the full library · About the Tower of Babel